Menu Search
Equities

Actinogen Medical Ltd

ATGGF:PKC

Actinogen Medical Ltd

Actions
  • Price (USD)0.015
  • Today's Change0.00 / 0.00%
  • Shares traded60.00k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Oct 31 2024 23:06 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Actinogen Medical Ltd's revenues fell -20.63% from 366.65k to 291.02k. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 10.75m to a larger loss of 13.04m.
Gross margin--
Net profit margin-4,482.26%
Operating margin-4,454.95%
Return on assets-71.44%
Return on equity-78.81%
Return on investment-78.20%
More ▼

Cash flow in AUDView more

In 2024, Actinogen Medical Ltd increased its cash reserves by 11.71%, or 990.67k. Cash Flow from Financing totalled 17.95m or 6,167.85% of revenues. In addition the company used 16.95m for operations while cash used for investing totalled 8.16k.
Cash flow per share-0.0055
Price/Cash flow per share--
Book value per share0.0072
Tangible book value per share0.0065
More ▼

Balance sheet in AUDView more

Actinogen Medical Ltd has a strong Balance Sheet and has consistently grown its cash reserves over the last Four years to total 9.45m.
Current ratio13.91
Quick ratio--
Total debt/total equity0.0162
Total debt/total capital0.0159
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.